Endometrial Cancer Initial Results of Conservative Hormonal Treatment in Postmenopausal Patients: A Possible New Trend?

The hormonal treatment with progestins, in low-grade G1 endometrioid endometrial cancers, has been approved as an alternative fertility-sparing treatment in young patients, under 40 years old, with fertility wishes and the possibility of close follow-up. However, it’s use in postmenopausal patients continues being debated. Objective: To analyze the short and medium-term results of conservative hormonal treatment applied to postmenopausal patients with low grade G1 endometroid endometrial cancer.